CNBC Halftime Report Final Trades: Nasdaq, Energy Transfer LP, Hilton Worldwide, Ventas
CNBC Halftime Report Final Trades: Nasdaq, Energy Transfer LP, Hilton Worldwide,
Citigroup Raises Ventas' Price Target to $59 From $50, Buy Rating Maintained
Ventas (VTR) has an average outperform rating and a price target range of $49 to $69, according to analysts polled by Capital IQ.Price: 51.97, Change: -0.48, Percent Change: -0.92
Big Real Estate Stocks Kick off H2 With Loss as State of the Sector Weighs on Sentiment
Ventas (VTR) Hits 52-Week High: Will the Stock Trend Higher?
Shares of Ventas VTR scaled a new 52-week high of $51.94 on Jul 3.
REITs Continue to Reduce NAV Discount Amid Increased Rate Cut Hopes
CoStar, Weyerhaeuser, Prologis in Worst-performing Q2 S&P 500 Real Estate Stocks
Ventas Inc To Go Ex-Dividend On July 1st, 2024 With 0.45 USD Dividend Per Share
June 27th (Eastern Time) - $Ventas Inc(VTR.US)$ is trading ex-dividend on July 1st, 2024.Shareholders of record on July 1st, 2024 will receive 0.45 USD dividend per share on July 18th, 2024. The ex-di
Real Estate Stocks Edge Down, While Major Market Averages Gain Marginally
Equity Group-Backed Ardent Health Files for IPO in Second Try
Ardent Health Partners Files for IPO
By Claudia Assis Hospital operator is backed by investment firm founded by Sam Zell Hospital operator Ardent Health Partners, which is backed by an investment firm founded by the late real-estate ma
Ardent Health Partners Seeking NYSE Listing Under Symbol ARDT
Ardent Health Partners Seeking NYSE Listing Under Symbol ARDT
Ardent Health Partners Stockholders Include Ventas and Pure Health Holding
Ardent Health Partners Stockholders Include Ventas and Pure Health Holding
Ardent Health Partners Is Backed by Sam Zell's Equity Group
Ardent Health Partners Is Backed by Sam Zell's Equity Group
Raymond James Adjusts Price Target on Ventas to $55 From $50.26
Ventas (VTR) has an average outperform rating and a price target range of $49 to $69, according to analysts polled by Capital IQ.
Express News | Ventas Inc : Raymond James Raises Target Price to $55 From $50.26
BNP Paribas Exane Adjusts Price Target on Ventas to $59 From $54
Ventas (VTR) has an average outperform rating and a price target range of $49 to $69, according to analysts polled by Capital IQ.
Baird Adjusts Price Target on Ventas to $51 From $49
Ventas (VTR) has an average rating of outperform and price targets ranging from $49 to $69, according to analysts polled by Capital IQ.
Express News | Ventas Inc : BMO Raises Target Price to $57 From $53
BMO Capital Adjusts Price Target on Ventas to $57 From $53, Keeps Outperform Rating
Ventas (VTR) has an average outperform rating and a price target range of $49 to $69, according to analysts polled by Capital IQ.
Scotiabank Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $52
Scotiabank analyst Nicholas Yulico maintains $Ventas Inc(VTR.US)$ with a hold rating, and adjusts the target price from $51 to $52.According to TipRanks data, the analyst has a success rate of 50.0% a